home / stock / srzn / srzn news

SRZN News and Press, Surrozen Inc. From 05/05/22

Stock Information
Company Name: Surrozen Inc.
Stock Symbol: SRZN
Market: NASDAQ
Website: surrozen.com
Menu
SRZN SRZN Quote SRZN Short SRZN News SRZN Articles SRZN Message Board
Get SRZN Alerts

News, Short Squeeze, Breakout and More Instantly...
SRZN - Surrozen to Present at the BofA Securities 2022 Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced tha...
SRZN - Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

SOUTH SAN FRANCISCO, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, announced today that a poster supporting the potential of SZN-413 for the...

SRZN - Tracking Baker Brothers Portfolio - Q4 2021 Update

Baker Brothers’ 13F portfolio value decreased from $22.77B to $20.55B this quarter. Incyte and Legend Biotech stakes were increased this quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~63% of the portfolio. For f...

SRZN - Surrozen GAAP EPS of -$2.21 beats by $0.09

Surrozen press release (NASDAQ:SRZN): FY GAAP EPS of -$2.21 beats by $0.09. Cash Position: Cash, cash equivalents and marketable securities were $123.5 million as of December 31, 2021, compared to $135.4 million as of September 30, 2021. For further details see: Surrozen GAAP EPS of -$2...
SRZN - Surrozen Reports Fourth Quarter and Full Year 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today reported fi...

SRZN - CPSH and SRZN among mid-day movers

Gainers: Sunshine Biopharma (NASDAQ:SBFM) +183%. Bumble (NASDAQ:BMBL) +42%. Bone Biologics (OTCPK:BBLG) +36%. Cano Health (NYSE:CANO) +35%. CPS Technologies (NASDAQ:CPSH) +29%. AST SpaceMobile (NASDAQ:ASTS) +31%. Hudson Technologies (NASDAQ:HDSN) +30%. FIGS (NYSE:FIGS) +30%. Fluent (NASDAQ:FL...

SRZN - HOOKIPA, Kinnate Biopharma top healthcare gainers; Masimo, Baudax Bio lead losers pack

Gainers: HOOKIPA Pharma (NASDAQ:HOOK) +46%. Kinnate Biopharma (NASDAQ:KNTE) +9%. Corcept Therapeutics (NASDAQ:CORT) +7%. Alkermes (NASDAQ:ALKS) +5%. Celularity (NASDAQ:CELU) +3%. Losers: Masimo (NASDAQ:MASI) -36%. Baudax Bio (NASDAQ:BXRX) -20%. ...
SRZN - Surrozen Announces Key 2022 Milestones for Lead Programs and Acceleration of Research Pipeline

-Initiation of Phase 1 clinical trials of SZN-1326 and SZN-043 expected in third quarter 2022 -Acceleration of preclinical programs includes nomination of lead candidate SZN-413 for retinopathies and compelling preclinical data highlighting the potential for lacrimal gland...

SRZN - Surrozen to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, will present ...

SRZN - Surrozen (SRZN) Investor Presentation - Slideshow

The following slide deck was published by Surrozen, Inc. in conjunction with this event. For further details see: Surrozen (SRZN) Investor Presentation - Slideshow

Previous 10 Next 10